Tudor Investment Corporation »

Silverback Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2026-06-30 $368k 46k 8.01

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)
Nvidia Corp - US Equity (NVDA)
Micron Technology Inc - US Equity (MU)
Microsoft Corp - US Equity (MSFT)
Ishares Core S&P 500 Etf - US ETP ETF Option Call Option (IVV)
Tesla Inc - US Equity (TSLA)
Ishares Iboxx High Yield Corporate Bond Etf - US E ETF Option Put Option (HYG)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Advanced Micro Devices Inc - US Equity (AMD)
Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Silverback Therapeutics

RA Capital Management
Rubric Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Tyro Capital Management
Standard Life Aberdeen
Sr One Capital Management
State Street Corporation
Vanguard Capital Management
Millennium Management
Janney Montgomery Scott
UBS Group
Geode Capital Management
Boothbay Fund Management

View all funds holding Silverback Therapeutics